These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32178236)

  • 1. A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant
    Nour El-Din HT; Elhosseiny NM; El-Gendy MA; Mahmoud AA; Hussein MMM; Attia AS
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32178236
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation, characterization and efficacy of lysostaphin-chitosan gel against Staphylococcus aureus.
    Nithya S; Nimal TR; Baranwal G; Suresh MK; C P A; Anil Kumar V; Gopi Mohan C; Jayakumar R; Biswas R
    Int J Biol Macromol; 2018 Apr; 110():157-166. PubMed ID: 29410001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLGA nanoparticle-encapsulated lysostaphin for the treatment of Staphylococcus aureus infections.
    Landa G; Aguerri L; Irusta S; Mendoza G; Arruebo M
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132563. PubMed ID: 38782313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant
    Hajiahmadi F; Alikhani MY; Shariatifar H; Arabestani MR; Ahmadvand D
    Int J Nanomedicine; 2019; 14():5943-5955. PubMed ID: 31447553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of activity of recombinant lysostaphin against isolates of meticillin-resistant Staphylococcus aureus from Indian hospitals.
    Kumar A; Khan IA; Sharma PR; K S; Ella KM
    J Med Microbiol; 2014 May; 63(Pt 5):763-766. PubMed ID: 24623634
    [No Abstract]   [Full Text] [Related]  

  • 6. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
    Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
    Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung-Targeting Lysostaphin Microspheres for Methicillin-Resistant
    Lin X; He J; Li W; Qi Y; Hu H; Zhang D; Xu F; Chen X; Zhou M
    ACS Nano; 2021 Oct; 15(10):16625-16641. PubMed ID: 34582183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of lysostaphin against Staphylococcus aureus.
    Jayakumar J; Kumar VA; Biswas L; Biswas R
    J Appl Microbiol; 2021 Sep; 131(3):1072-1082. PubMed ID: 33382154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).
    Desbois AP; Lang S; Gemmell CG; Coote PJ
    J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial and antibiofilm surfaces through polydopamine-assisted immobilization of lysostaphin as an antibacterial enzyme.
    Yeroslavsky G; Girshevitz O; Foster-Frey J; Donovan DM; Rahimipour S
    Langmuir; 2015 Jan; 31(3):1064-73. PubMed ID: 25547537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP; Gemmell CG; Coote PJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomimetic Designer Cells Protect Mice from MRSA Infection.
    Liu Y; Bai P; Woischnig AK; Charpin-El Hamri G; Ye H; Folcher M; Xie M; Khanna N; Fussenegger M
    Cell; 2018 Jul; 174(2):259-270.e11. PubMed ID: 29937224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
    Placencia FX; Kong L; Weisman LE
    Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptidase lysostaphin at subinhibitory concentrations modulates staphylococcal adherence, biofilm formation, and toxin production.
    Yue Y; Chen K; Sun C; Ahmed S; Ojha SC
    BMC Microbiol; 2023 Oct; 23(1):311. PubMed ID: 37884887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
    Tellis M; Joseph J; Khande H; Bhagwat S; Patel M
    J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Lysostaphin functionalized silicon catheter for the prevention of Staphylococcus aureus biofilm.
    Jayakumar J; Vinod V; Arumugam T; Sathy BN; Biswas L; Kumar VA; Biswas R
    Int J Biol Macromol; 2024 Jan; 256(Pt 2):128547. PubMed ID: 38048926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nisin and lysostaphin activity against preformed biofilm of Staphylococcus aureus involved in bovine mastitis.
    Ceotto-Vigoder H; Marques SL; Santos IN; Alves MD; Barrias ES; Potter A; Alviano DS; Bastos MC
    J Appl Microbiol; 2016 Jul; 121(1):101-14. PubMed ID: 26999597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains.
    Giordani B; Costantini PE; Fedi S; Cappelletti M; Abruzzo A; Parolin C; Foschi C; Frisco G; Calonghi N; Cerchiara T; Bigucci F; Luppi B; Vitali B
    Eur J Pharm Biopharm; 2019 Jun; 139():246-252. PubMed ID: 30991089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW; Patron RL; Goldstein BP; Archer GL
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.